Literature DB >> 10208970

Angiotensin II interacts with prostaglandin F2alpha and endothelin-1 as a local luteolytic factor in the bovine corpus luteum in vitro.

K Hayashi1, A Miyamoto.   

Abstract

Recent findings suggest that the ovarian renin-angiotensin system may regulate ovarian function through the paracrine/autocrine actions of angiotensin II (Ang II). In this study, we have examined and characterized the local effects of Ang II as a luteolytic factor and its interaction with prostaglandin F2alpha (PGF2alpha) and endothelin-1 (ET-1) in the bovine corpus luteum (CL) of the mid-luteal phase, by using an in vitro microdialysis system (MDS). Ang II was detected in the MDS perfusate (4 pg/ml), and infusion of PGF2alpha (10(-6) M) for 2 h increased the Ang II release by 50-100% during the following experimental period, in addition to its stimulation of ET-1 release. Two 2-h infusions of Ang II (10(-7)-10(-5) M) separated by a 2-h interval induced a dose- and time-dependent decrease of progesterone (P4) release by 41-66%. When the luteal explants were pre-perfused with PGF2alpha (10(-6) M) for 2 h, two consecutive perfusions of Ang II (10(-6) M) at a 2-h interval rapidly reduced the P4 release (by 50%). This reduction occurred 6 h earlier than those of infusions of PGF2alpha or Ang II alone. The simultaneous infusion of either 1) Ang II (10(-6) M) with PGF2alpha (10(-6) M), 2) ET-1 (10(-7) M) with PGF2alpha, or 3) Ang II + ET-1 with PGF2alpha (10(-6) M) for 2 h also induced a rapid and pronounced (60%) decrease in P4 release. Perfusion with the Ang II antagonist blocked the P4-suppressing activity of Ang II alone or PGF2alpha + Ang II infusion. Ang II stimulated the release of ET-1 and oxytocin during infusion but inhibited them after infusion. These results show that Ang II is released in the bovine midcycle CL in vitro, and this peptide, either alone or together with PGF2alpha, can suppress the release of P4. As PGF2alpha directly stimulated Ang II release, Ang II may influence the critical period for starting the cascade of functional luteolysis in vivo and might lead to structural luteolysis with ET-1 as a major vasoconstrictor. The overall results suggest that Ang II may have an important role at luteolysis in the bovine CL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208970     DOI: 10.1095/biolreprod60.5.1104

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  6 in total

1.  The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy.

Authors:  Bajram Berisha; Dieter Schams; Akio Miyamoto
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.

Authors:  Jing Sun; Haijian Fan; Yena Che; Yunxia Cao; Xiaoke Wu; Hai-xiang Sun; Fengjing Liang; Long Yi; Yong Wang
Journal:  BMC Med Genet       Date:  2009-07-14       Impact factor: 2.103

3.  Downregulated luteolytic pathways in the transcriptome of early pregnancy bovine corpus luteum are mimicked by interferon-tau in vitro.

Authors:  Raghavendra Basavaraja; Jessica N Drum; Jackson Sapuleni; Lonice Bibi; Gilgi Friedlander; Sai Kumar; Roberto Sartori; Rina Meidan
Journal:  BMC Genomics       Date:  2021-06-16       Impact factor: 3.969

Review 4.  Microvascular endothelial cells of the corpus luteum.

Authors:  John S Davis; Bo R Rueda; Katherina Spanel-Borowski
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

5.  Downregulation of lymphatic vessel formation factors in PGF2α-induced luteolysis in the cow.

Authors:  Akane Nitta; Koumei Shirasuna; Sayo Nibuno; Heinrich Bollwein; Takashi Shimizu; Akio Miyamoto
Journal:  J Reprod Dev       Date:  2013-03-25       Impact factor: 2.214

6.  The role of GPR1 signaling in mice corpus luteum.

Authors:  Ya-Li Yang; Li-Rong Ren; Li-Feng Sun; Chen Huang; Tian-Xia Xiao; Bao-Bei Wang; Jie Chen; Brian A Zabel; Peigen Ren; Jian V Zhang
Journal:  J Endocrinol       Date:  2016-05-05       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.